We found that the expressions of SYT4, SYT9, and SYT14 at the mRNA and protein levels were significantly up-regulated in GC patients compared with the healthy controls, leading to the unsatisfactory OS and PFS for GC patients. This evidence concerns the gene SYT9 and gastric cancer.